Transmedics Group Inc (NASDAQ: TMDX) is 17.26% higher on its value in year-to-date trading and has touched a low of $55.00 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $68.27 in the last trading session, with the day’s gains setting it 4.84%.
Currently trading at $73.11, the stock is 6.61% and 5.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing 7.09% at the moment leaves the stock -32.09% off its SMA200. TMDX registered -0.44% loss for a year compared to 6-month loss of -53.43%. The firm has a 50-day simple moving average (SMA 50) of $69.5579 and a 200-day simple moving average (SMA200) of $107.6537.
The stock witnessed a 5.79% gain in the last 1 month and extending the period to 3 months gives it a 23.33%, and is 3.97% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.35% over the week and 5.49% over the month.
Transmedics Group Inc (TMDX) has around 728 employees, a market worth around $2.46B and $441.54M in sales. Current P/E ratio is 72.37 and Fwd P/E is 32.51. Profit margin for the company is 8.03%. Distance from 52-week low is 32.93% and -58.78% from its 52-week high. The company has generated returns on investments over the last 12 months (4.77%).
with sales reaching $123.39M over the same period.The EPS is expected to grow by 45.00% this year, but quarterly earnings will post 22.42% year-over-year. Quarterly sales are estimated to grow 27.41% in year-over-year returns.
435.0 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 120.33% of the company’s shares. The shares outstanding are 33.62M, and float is at 32.43M with Short Float at 29.45%. Institutions hold 116.12% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.5576 of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 7.9879 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.7118 and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.487 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 2,407 shares of the company’s common stock on Mar 03 ’25 at a price of $76.43 per share for a total of $0.18 million. Following the sale, the insider now owns 36042.0 shares.
Still, SEC filings show that on Jan 07 ’25, Khayal Tamer I (Chief Commercial Officer) disposed off 1,083 shares at an average price of $80.05 for $86694.0. The insider now directly holds 20,843 shares of Transmedics Group Inc (TMDX).
